Health Care: Drugs

Pain Therapeutics Inc. (PTIE: NASDAQ)

$2.89 0.09 | 3.21%
05/17/13 - 04:00 PM ET
Company Profile
Price and Volume
Recent Price 2.89
52 Week High 5.86
52 Week Low 2.34
Avg. Daily Vol. (Mil) 0.32
Beta (3 year) 0.66
Share Related Items
Mkt Cap (Mil) 131.01
Shares Out (Mil) 45.33
Float (Mil) 37.92
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 5.60
Current Ratio 5.60
LT Debt/ Equity 0.00
Total Debt / Equity 0.00
Valuation Ratios
Price Earnings n.a.
Price/Sales 13.27
Price/Book 9.77
Price/Cash Flow -34.50
Per Share Data
Earnings -0.08
Sales 0.22
Book Value 0.30
Cash Flow -0.08
Business Summary
Pain Therapeutics, Inc., is a biopharmaceutical company that develops novel drugs. It has four drug candidates in clinical programs, including Remoxy, Oxytrex, PTI-202 and a novel radio-labeled monoclonal antibody to treat metastatic melanoma.
General Information
7801 N. Capital of Texas Hig
Suite 260
Austin, TX 78731
www.paintrials.com
Industry : Drugs
Sector: Health Care
Employees: 8
CEO: Remi Barbier
Short Interest
Current Month (Mil) 1.34
Previous Month (Mil) 1.21
Short Interest Ratio (Days) 5.40
Management Effectiveness
Return on Equity n.a.
Return on Assets -7.10
Return on Investments -28.00
Profitability
Gross Margin n.a.
EBIT Margin -40.20
Profit Margin -39.30

Portfolios with PTIE

Latest PTIE Headlines from TheStreet

More Financial News for PTIE

Press Releases for PTIE

See All Press Releases

Partner Headlines for PTIE

brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter